This effect can reduce the appearance of wrinkles and treat conditions like chronic migraines, excessive sweating, and muscle spasms
Claims could arise around weight-loss drugs from a variety of sources: retail pharmacy portfolios, private medical and wellness providers, online healthcare intermediaries, distributors, or manufacturers based in the U.S., EU, UK, or further afield
In sum, most studies suggest that GLP-1 RAs do not increase the risk of suicide, with some indicating potential benefits
Triumph-2 enrolled 1,152 adults with type 2 diabetes and obesity or overweight, randomized to Retatrutide 4 mg, 9 mg, 12 mg, or placebo over 80 weeks
Identifying relevant studies for systematic reviews